56 related articles for article (PubMed ID: 10201920)
1. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
[TBL] [Abstract][Full Text] [Related]
2. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells.
Ho EL; Heusel JW; Brown MG; Matsumoto K; Scalzo AA; Yokoyama WM
Proc Natl Acad Sci U S A; 1998 May; 95(11):6320-5. PubMed ID: 9600963
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
Malmberg KJ; Levitsky V; Norell H; de Matos CT; Carlsten M; Schedvins K; Rabbani H; Moretta A; Söderström K; Levitskaya J; Kiessling R
J Clin Invest; 2002 Nov; 110(10):1515-23. PubMed ID: 12438449
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse.
Sanni TB; Masilamani M; Kabat J; Coligan JE; Borrego F
Mol Biol Cell; 2004 Jul; 15(7):3210-23. PubMed ID: 15133125
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.
Ince MN; Harnisch B; Xu Z; Lee SK; Lange C; Moretta L; Lederman M; Lieberman J
Immunology; 2004 Aug; 112(4):531-42. PubMed ID: 15270723
[TBL] [Abstract][Full Text] [Related]
6. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.
Nickoloff BJ; Wrone-Smith T
Am J Pathol; 1999 Jul; 155(1):145-58. PubMed ID: 10393847
[TBL] [Abstract][Full Text] [Related]
7. Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival.
Verma K; Croft W; Pearce H; Zuo J; Stephens C; Nunnick J; Kinsella FA; Malladi R; Moss P
Haematologica; 2023 Feb; 108(2):433-443. PubMed ID: 35924575
[TBL] [Abstract][Full Text] [Related]
8. KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.
Cheray M; Bessette B; Lacroix A; Mélin C; Jawhari S; Pinet S; Deluche E; Clavère P; Durand K; Sanchez-Prieto R; Jauberteau MO; Battu S; Lalloué F
J Cell Mol Med; 2017 Feb; 21(2):244-253. PubMed ID: 27641066
[TBL] [Abstract][Full Text] [Related]
9. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.
Vance RE; Jamieson AM; Raulet DH
J Exp Med; 1999 Dec; 190(12):1801-12. PubMed ID: 10601355
[TBL] [Abstract][Full Text] [Related]
10. Diversity of NKG2C genotypes in a European population: Conserved and recombinant haplotypes in the coding, promoter, and 3'-untranslated regions.
Asenjo J; Moraru M; Al-Akioui-Sanz K; Altadill M; Muntasell A; López-Botet M; Vilches C
HLA; 2022 Nov; 100(5):469-478. PubMed ID: 35802353
[TBL] [Abstract][Full Text] [Related]
11. Towards Clinical Translation of CD8
Wasnik S; Baylink DJ; Leavenworth J; Liu C; Bi H; Tang X
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569411
[TBL] [Abstract][Full Text] [Related]
12. The Paradoxical Role of NKG2D in Cancer Immunity.
Sheppard S; Ferry A; Guedes J; Guerra N
Front Immunol; 2018; 9():1808. PubMed ID: 30150983
[TBL] [Abstract][Full Text] [Related]
13. NKG2H-Expressing T Cells Negatively Regulate Immune Responses.
Dukovska D; Fernández-Soto D; Valés-Gómez M; Reyburn HT
Front Immunol; 2018; 9():390. PubMed ID: 29545803
[TBL] [Abstract][Full Text] [Related]
14. Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.
Liu Y; Zeng G
J Immunother; 2012 May; 35(4):299-308. PubMed ID: 22495387
[TBL] [Abstract][Full Text] [Related]
15. Global transcriptional analysis delineates the differential inflammatory response interleukin-15 elicits from cultured human T cells.
Ramsborg CG; Papoutsakis ET
Exp Hematol; 2007 Mar; 35(3):454-464. PubMed ID: 17309826
[TBL] [Abstract][Full Text] [Related]
16. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.
Borrego F; Masilamani M; Marusina AI; Tang X; Coligan JE
Immunol Res; 2006; 35(3):263-78. PubMed ID: 17172651
[TBL] [Abstract][Full Text] [Related]
17. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
Du Z; Gjertson DW; Reed EF; Rajalingam R
Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
[TBL] [Abstract][Full Text] [Related]
18. The role of CD94/NKG2 in innate and adaptive immunity.
Gunturi A; Berg RE; Forman J
Immunol Res; 2004; 30(1):29-34. PubMed ID: 15258309
[TBL] [Abstract][Full Text] [Related]
19. CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes.
Werwitzke S; Tiede A; Drescher BE; Schmidt RE; Witte T
Clin Exp Immunol; 2003 Sep; 133(3):334-43. PubMed ID: 12930358
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
